Selective PDE4 Inhibitors as Potent Anti-Inflammatory Drugs for the Treatment of Airway Diseases

Memorias do Instituto Oswaldo Cruz - Brazil
doi 10.1590/s0074-02762005000900023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Synthesis of Pyrrolo[2,3-D]pyridazinones as Potent, Subtype Selective PDE4 Inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2007English

Recent Advances in PDE4 Inhibitors as Immunoregulators and Antiinflammatory Drugs

2012English

Nonsteroidal Anti-Inflammatory Drugs as Potential Ecto-Nucleotide Phosphodiesterase Inhibitors

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Identification of Anti-Inflammatory and Anti-Hypertensive Drugs as Inhibitors of Bacterial Diguanylate Cyclases

Journal of the Brazilian Chemical Society
Chemistry
2017English

Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment

Frontiers in Immunology
AllergyImmunology
2018English

Natural Product-Derived Drugs for the Treatment of Inflammatory Bowel Diseases

Intestinal Research
Gastroenterology
2014English

Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP4 Inhibitors for the Treatment of Type 2 Diabetes

English

The Effect of Selective Phosphodiesterase 3 and 4 Isoenzyme Inhibitors and Established Anti-Asthma Drugs on Inflammatory Cell Activation

British Journal of Pharmacology
Pharmacology
1996English

Functionalized N,NDiphenylamines as Potent and Selective EPAC2 Inhibitors

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy